No Prostate Cancer Survival Benefit With More Extensive Lymph Node Assessment
WASHINGTON — Extended pelvic lymph node dissection (ePLND) after radical prostatectomy failed to improve survival in intermediate- and high-risk prostate cancer over standard lymphadenectomy, long-term follow-up from a randomized trial showed. After a median follow-up of almost 11 years, more extensive lymph node assessment did not significantly improve any survival outcome in the overall patient…
